SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-039615
Filing Date
2013-05-09
Accepted
2013-05-09 16:29:45
Documents
7
Period of Report
2013-05-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-11504_38k.htm 8-K 31112
2 EX-1.1 a13-11504_3ex1d1.htm EX-1.1 236155
3 EX-5.1 a13-11504_3ex5d1.htm EX-5.1 10398
4 EX-99.1 a13-11504_3ex99d1.htm EX-99.1 11853
5 EX-99.2 a13-11504_3ex99d2.htm EX-99.2 11382
6 GRAPHIC g115043moi001.jpg GRAPHIC 2928
7 GRAPHIC g115043mmi001.jpg GRAPHIC 2928
  Complete submission text file 0001104659-13-039615.txt   310318
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 13829322
SIC: 2834 Pharmaceutical Preparations